Oli: Can Artificial Intelligence Support Personal Well-Being? Custom Case Solution & Analysis

Evidence Brief: Oli Health

1. Financial Metrics

• Seed Funding: 2.5 million dollars raised in initial round (Exhibit 1).
• B2C Pricing: 15 dollars per user per month for premium features (Paragraph 8).
• Market Opportunity: 221 billion dollar global spend on mental health services (Exhibit 3).
• Customer Acquisition Cost: Estimated at 45 dollars per user in the B2C segment (Paragraph 12).
• Operating Burn: 180,000 dollars monthly, primarily driven by engineering and clinical staff (Exhibit 4).

2. Operational Facts

• Core Technology: Proprietary Natural Language Processing engine trained on Cognitive Behavioral Therapy protocols (Paragraph 4).
• Headcount: 14 full-time employees including 6 software engineers and 3 clinical psychologists (Paragraph 6).
• User Base: 50,000 registered users with 12 percent monthly active usage (Paragraph 9).
• Data Infrastructure: Cloud-based hosting with encryption, currently seeking full HIPAA certification (Paragraph 15).

3. Stakeholder Positions

• Sarah Chen (CEO): Advocates for rapid user growth via B2C channels to build brand recognition (Paragraph 3).
• David Miller (Clinical Lead): Concerned about clinical boundaries and the risk of users misinterpreting AI advice during crises (Paragraph 11).
• Board of Directors: Pressuring for a clear path to profitability within 18 months (Paragraph 14).
• Corporate HR Managers: Interested in digital tools to reduce employee absenteeism but require evidence of efficacy (Paragraph 18).

4. Information Gaps

• Long-term user retention data beyond the initial 90-day window is missing.
• Specific churn rates for the premium subscription tier are not disclosed.
• Comparative efficacy data against traditional tele-therapy competitors is unavailable.

Strategic Analysis

1. Core Strategic Question

• Should Oli Health focus on the high-volume but high-churn B2C market or pivot to a B2B model targeting corporate employers and insurers to ensure financial stability?

2. Structural Analysis

The mental health app market is fragmented with low barriers to entry. Using the Five Forces lens, the threat of new entrants is extreme. Thousands of wellness apps compete for limited screen time. Bargaining power of buyers in B2C is high because switching costs are zero. However, the Jobs-to-be-Done for Oli is not just wellness; it is low-friction, stigma-free intervention. This differentiates Oli from meditation apps and positions it closer to clinical support.

3. Strategic Options

4. Preliminary Recommendation

Oli Health should pursue the B2B Enterprise Pivot. The B2C model is a race to the bottom on price and a race to the top on marketing costs. Corporate contracts provide the recurring revenue necessary to fund the clinical trials required for long-term legitimacy. The company must reposition the product as a productivity and retention tool for employers.

Implementation Roadmap

1. Critical Path

• Month 1: Finalize HIPAA and SOC2 compliance audits to meet enterprise security requirements.
• Month 2: Launch a pilot program with three mid-sized technology firms to gather workplace-specific efficacy data.
• Month 3: Hire two enterprise sales leads with existing relationships in human resources and benefits administration.
• Month 4: Transition marketing budget from social media ads to industry conferences and white paper development.

2. Key Constraints

• Sales Cycle: Corporate HR decisions often take 6 to 9 months, creating a cash flow gap.
• Clinical Safety: The AI must have a fail-safe handoff to human crisis lines to prevent liability.
• Integration: Enterprise clients will demand integration with existing employee assistance programs.

3. Risk-Adjusted Implementation Strategy

The strategy assumes a 30 percent conversion rate from pilot to contract. To mitigate the long sales cycle, Oli will maintain a slim B2C presence to generate immediate cash, but all new feature development will focus on enterprise reporting and population health analytics. A contingency fund representing three months of runway will be set aside to cover delays in contract signatures.

Executive Review and BLUF

1. BLUF

Pivot immediately to a B2B model. The current B2C strategy is financially unviable due to high acquisition costs and the lack of a moat. Oli Health must target corporate employers where the value proposition is tied to reducing absenteeism and healthcare claims. Success requires shifting from a wellness brand to a data-driven clinical support tool. Stop all non-essential B2C marketing spend to preserve twelve months of runway for the enterprise transition.

2. Dangerous Assumption

The analysis assumes that corporate employers will accept an AI-only solution. If HR managers view AI as a liability rather than a cost-saving tool, the B2B sales pipeline will fail regardless of the technical efficacy of the product.

3. Unaddressed Risks

• Regulatory Risk: A change in FDA classification of mental health chatbots could halt operations overnight. Probability: Medium. Consequence: Fatal.
• Algorithmic Bias: The AI may perform poorly for specific demographic groups if the training data is skewed, leading to reputational damage. Probability: High. Consequence: Moderate.

4. Unconsidered Alternative

The team has not evaluated a white-label licensing model. Instead of building a brand, Oli could license its NLP engine to established telehealth providers or insurance companies. This would eliminate the need for a sales force and marketing budget, focusing the company entirely on engineering and clinical excellence.

5. MECE Verdict

APPROVED FOR LEADERSHIP REVIEW. The analysis covers the three distinct market paths (B2B, B2C, Clinical) without overlap and addresses the primary financial and operational hurdles facing the firm.